Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value of 0.01 per share
-
Shares outstanding
-
3,251,461
-
Total 13F shares
-
481,831
-
Share change
-
+96,204
-
Total reported value
-
$717,864
-
Price per share
-
$1.49
-
Number of holders
-
13
-
Value change
-
+$144,245
-
Number of buys
-
4
-
Number of sells
-
5
Institutional Holders of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (MYNZ) as of Q3 2025
As of 30 Sep 2025,
MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (MYNZ) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
481,831 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Dauntless Investment Group, LLC, Journey Advisory Group, LLC, Steward Partners Investment Advisory, LLC, UBS Group AG, OSAIC HOLDINGS, INC., Provenance Wealth Advisors, LLC, Newbridge Financial Services Group, Inc., SBI Securities Co., Ltd., and IFP Advisors, Inc.
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.